Ildong Pharmaceutical Co., Ltd. (249420.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 14,640.00

From 52W high−67.36%

Volume148673.00

Market capKRW 434.31B

P/E (TTM)10.2x

P/S (TTM)0.7x

Div yield1.38%

Key dataSep 18, 2026

Open

KRW 14,640.00

From 52W high

−67.36%

Volume

148673.00

Market cap

KRW 434.31B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−91.9x

P/E (TTM)

10.2x

RSI (14)

44.5

MomentumView details →

1D Return

+0.28%

YTD Return

−62.81%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

10.2x

EV/EBITDA

−91.9x

EV/Sales

0.9x

P/S (TTM)

0.7x

P/B (TTM)

1.7x

ProfitabilityView details →

Gross Margin

38.39%

Net Margin

7.49%

EBITDA Margin

−0.95%

ROE (TTM)

16.91%

ROA (TTM)

7.78%

Asset Turnover

1.04x

GrowthView details →

Revenue YoY

−0.65%

EPS YoY

+1696.70%

FCF YoY

—

Revenue CAGR 3Y

−3.85%

EPS CAGR 3Y

+675.74%

EBITDA YoY

—

MomentumView details →

1D Return

+0.28%

YTD Return

−62.81%

1Y Return

−52.35%

RSI (14)

44.5

vs 50D SMA

−1.80%

vs 200D SMA

−44.57%

Capital & dividendView details →

Debt/Equity

0.55x

Current Ratio

1.00x

Quick Ratio

0.56x

Div Yield

1.38%

Div Rate

KRW 200.00

Div Growth 1Y

+110.00%

EarningsView details →

EPS (Actual)

KRW 400.75

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

582.33B

Net Income (TTM)

43.61B

Op. CF (TTM)

35.44B

Latest newsMore news →

No recent news for 249420.KS.

Similar companies

Bukwang Pharmaceutical Co., Ltd.003000.KS Shinpoong Pharmaceutical Co., Ltd.019170.KS JW Pharmaceutical Corporation001065.KS Dong-A ST Co., Ltd.170900.KS Kwang Dong Pharmaceutical Co., Ltd.009290.KS 恒瑞医药600276.SH Find similar companies →

Latest newsMore news →

No recent news for 249420.KS.